# 83301-0081-2 · Bumetanide Injection · Mullan Pharmaceutical Inc. — FDA drug shortage duration tracker

For 83301-0081-2 · Bumetanide Injection · Mullan Pharmaceutical Inc., package ndc is 83301-0081-2; generic name is Bumetanide Injection; manufacturer is Mullan Pharmaceutical Inc; status is Current; availability now is Available, recorded from its source on 2026-09-01.

- **Package NDC:** 83301-0081-2 _(verified: appears in the quote below)_
- **Generic name:** Bumetanide Injection _(verified: appears in the quote below)_
- **Manufacturer:** Mullan Pharmaceutical Inc. _(verified: appears in its own passage below)_
- **Status:** Current _(verified: appears in its own passage below)_
- **Availability now:** Available _(verified: appears in the quote below)_
- **Initial posting date:** 12/13/2017 _(verified: appears in the quote below)_
- **Last update date:** 08/11/2026 _(verified: appears in its own passage below)_
- **Days in shortage:** 3184 _(our reading, not quoted from the source)_
- **Dosage form:** Injection _(verified: appears in its own passage below)_
- **Therapeutic category:** Cardiovascular _(verified: appears in its own passage below)_

## What the source says

> "initial_posting_date": "12/13/2017", "package_ndc": "83301-0081-2", "generic_name": "Bumetanide Injection", "contact_info": "800-673-9839", "availability": "Available"

## Where each value comes from

This source states these in separate places, so each value is shown with the passage that states it.

### Manufacturer

> "update_date": "08/11/2026", "therapeutic_category": [ "Cardiovascular" ], "dosage_form": "Injection", "presentation": "Bumetanide, Injection, 2.5 mg/10 mL (0.25 mg/mL) (NDC 83301-0081-2)", "company_name": "Mullan Pharmaceutical Inc.", "status": "Current"

### Status

> "update_date": "08/11/2026", "therapeutic_category": [ "Cardiovascular" ], "dosage_form": "Injection", "presentation": "Bumetanide, Injection, 2.5 mg/10 mL (0.25 mg/mL) (NDC 83301-0081-2)", "company_name": "Mullan Pharmaceutical Inc.", "status": "Current"

### Last update date

> "update_date": "08/11/2026", "therapeutic_category": [ "Cardiovascular" ], "dosage_form": "Injection", "presentation": "Bumetanide, Injection, 2.5 mg/10 mL (0.25 mg/mL) (NDC 83301-0081-2)", "company_name": "Mullan Pharmaceutical Inc.", "status": "Current"

### Dosage form

> "update_date": "08/11/2026", "therapeutic_category": [ "Cardiovascular" ], "dosage_form": "Injection", "presentation": "Bumetanide, Injection, 2.5 mg/10 mL (0.25 mg/mL) (NDC 83301-0081-2)", "company_name": "Mullan Pharmaceutical Inc.", "status": "Current"

### Therapeutic category

> "update_date": "08/11/2026", "therapeutic_category": [ "Cardiovascular" ], "dosage_form": "Injection", "presentation": "Bumetanide, Injection, 2.5 mg/10 mL (0.25 mg/mL) (NDC 83301-0081-2)", "company_name": "Mullan Pharmaceutical Inc.", "status": "Current"

## Source

- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mullan%20Pharmaceutical%20Inc.%22+AND+generic_name%3A%22Bumetanide%20Injection%22+AND+status%3A%22Current%22&limit=1000

Last verified: 2026-09-01. Review by: 2026-09-04.
Part of [FDA drug shortage duration tracker](https://referencesource.org/drug-shortage-duration-tracker/).